DAVID ABRAHAM MANKOFF MD PHD NPI 1497840896

NPI Details

David Abraham Mankoff, MD, PHD is a nuclear medicine in Philadelphia, PA with 38 years of experience. The provider is a nuclear medicine specialist employs the properties of radioactive atoms and molecules in the diagnosis and treatment of disease and in research. Radiation detection and imaging instrument systems are used to detect disease as it changes the function and metabolism of normal cells, tissues and organs. A wide variety of diseases can be found in this way, usually before the structure of the organ involved by the disease can be seen to be abnormal by any other techniques. Early detection of coronary artery disease (including acute heart attack), early cancer detection and evaluation of the effect of tumor treatment, diagnosis of infection and inflammation anywhere in the body and early detection of blood clot in the lungs are all possible with these techniques. Unique forms of radioactive molecules can attack and kill cancer cells (e.g., lymphoma, thyroid cancer) or can relieve the severe pain of cancer that has spread to bone David Abraham Mankoff, MD, PHD NPI is 1497840896. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: PERELMAN SCHOOL OF MED AT THE UNIVERSITY OF PENNSYLVANIA
Graduation Year:1988

The provider's business location address is:

3400 SPRUCE STREET
PHILADELPHIA, PA
ZIP 19104-206
Phone: (215) 614-1926

The NPI 1497840896 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
• Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
• Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
• Nuclear medicine study whole body with ct scan (HCPCS:78816)
• Nuclear medicine study whole body with ct scan (HCPCS:78816)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)

The enumeration date for this NPI number is 10/3/2006 and was last updated on 6/5/2012.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: